QI
TNDM icon

QS Investors’s Tandem Diabetes Care TNDM Stock Holding History

QS Investors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-800
Closed -$80K – 1524
2020
Q2 		$80K Hold
800
– – ﹤0.01% 1384
2020
Q1 		$52K Hold
800
– – ﹤0.01% 1398
2019
Q4 		$49K Hold
800
– – ﹤0.01% 1462
2019
Q3 		$48K Hold
800
– – ﹤0.01% 1483
2019
Q2 		$52K Buy
+800
New +$51.6K ﹤0.01% 1489

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

QS Investors's TNDM Position: Q3 2020 in Review

QS Investors sold out of Tandem Diabetes Care (TNDM) in Q3 2020, closing a stake of 800 shares — an estimated $80K sold.

QS Investors first reported a position in TNDM in Q2 2019 and held it in 5 quarters. The position peaked at $80K in Q2 2020. 321 funds tracked by Wall St. Rank hold TNDM as of Q3 2020.

  • QS Investors reported no remaining Tandem Diabetes Care position as of Q3 2020 after selling out during the quarter.
  • QS Investors sold 800 Tandem Diabetes Care shares in Q3 2020, an estimated $80K.
  • QS Investors first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 5 quarters.
  • QS Investors's Tandem Diabetes Care position peaked at $80K in Q2 2020.
  • 321 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.